Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$18.56
-0.5%		$19.38
$13.46
▼
$31.04
$513.16M0.9314,533 shs140,468 shs
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
$13.37
-4.2%		$13.37
$10.26
▼
$15.98
$754.01MN/A584,408 shs1.18 million shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$3.45
-0.3%		$4.26
$2.56
▼
$7.32
$166.29M2.021.16 million shs679,931 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$5.19
+1.1%		$5.29
$2.32
▼
$6.67
$512.58M0.391.92 million shs1.26 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-0.48%-3.03%-11.66%+18.22%-14.75%
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
-3.67%+5.28%-5.58%-1.18%+1,336,999,900.00%
LifeMD, Inc. stock logo
LFMD
LifeMD
-0.29%-3.09%-23.84%-20.32%-49.93%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
0.00%0.00%-8.37%+30.30%+26.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$18.56
-0.5%		$19.38
$13.46
▼
$31.04
$513.16M0.9314,533 shs140,468 shs
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
$13.37
-4.2%		$13.37
$10.26
▼
$15.98
$754.01MN/A584,408 shs1.18 million shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$3.45
-0.3%		$4.26
$2.56
▼
$7.32
$166.29M2.021.16 million shs679,931 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$5.19
+1.1%		$5.29
$2.32
▼
$6.67
$512.58M0.391.92 million shs1.26 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-0.48%-3.03%-11.66%+18.22%-14.75%
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
-3.67%+5.28%-5.58%-1.18%+1,336,999,900.00%
LifeMD, Inc. stock logo
LFMD
LifeMD
-0.29%-3.09%-23.84%-20.32%-49.93%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
0.00%0.00%-8.37%+30.30%+26.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
2.00
Hold$27.5048.17% Upside
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
2.89
Moderate Buy$19.2243.77% Upside
LifeMD, Inc. stock logo
LFMD
LifeMD
2.60
Moderate Buy$7.57119.46% Upside
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
2.60
Moderate Buy$8.5063.90% Upside

Current Analyst Ratings Breakdown

Latest LFMD, GMRS, FLGT, and TOI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$5.00
8/7/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $9.00
8/6/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$5.00
8/6/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$7.00
8/6/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $8.00
8/6/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $9.00
8/4/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/4/2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$15.00 ➝ $19.00
7/17/2026
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/9/2026
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$8.00 ➝ $9.00
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$322.67M1.58N/AN/A$36.20 per share0.51
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
$5.83B0.12N/AN/A$14.61 per share0.92
LifeMD, Inc. stock logo
LFMD
LifeMD
$191.59M0.87N/AN/A$0.17 per share20.29
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$545.76M0.94N/AN/A($0.16) per share-32.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$60.51M-$2.82N/AN/AN/A-26.05%-4.93%-4.50%N/A
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/A$0.2847.757.640.23N/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
$14.35M-$0.05N/A28.75N/A0.10%-168.23%-31.27%N/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$60.61M-$0.37N/AN/AN/A-7.42%N/A-24.68%N/A

Latest LFMD, GMRS, FLGT, and TOI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
$0.38-$1.84-$2.22-$1.84N/A$1.49 billion
8/6/2026Q2 2026
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.07-$0.08-$0.01-$0.08$155.28 million$161.28 million
8/5/2026Q2 2026
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.1457-$0.16-$0.0143-$0.16$49.16 million$47.28 million
7/30/2026Q2 2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$0.46-$0.58-$0.12-$1.05$94.00 million$85.39 million
6/1/2026Q1 2026
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/A$0.28N/A$0.28N/A$1.46 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/AN/AN/AN/AN/A
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/A
6.34
6.34
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
5.50
2.01
1.87
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
0.90
0.84
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/A
1.47
1.17

Institutional Ownership

CompanyInstitutional Ownership
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
48.06%
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/A
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%

Insider Ownership

CompanyInsider Ownership
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
36.18%
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/A
LifeMD, Inc. stock logo
LFMD
LifeMD
17.22%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
4.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
1,31527.51 million17.56 millionOptionable
GMR Solutions Inc. stock logo
GMRS
GMR Solutions
N/A54.01 millionN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
23048.20 million39.90 millionOptionable
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
66098.84 million94.49 millionNot Optionable

Recent News About These Companies

Oncology Institute Q2 Earnings Call Highlights
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oncology-institute-q2-earnings-call-highlights-2026-08-07/
The Oncology Institute, Inc. $TOI Shares Bought by Arrowstreet Capital Limited Partnership
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-oncology-institute-inc-toi-shares-bought-by-arrowstreet-capital-limited-partnership-2026-08-07/
Oncology Institute (NASDAQ:TOI) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oncology-institute-nasdaqtoi-issues-quarterly-earnings-results-misses-estimates-by-001-eps-2026-08-06/
The Oncology Institute Officially Rebrands as Starling Oncology with New Nasdaq Ticker STLN
August 3, 2026  |  kalkinemedia.comK
Starling Oncology Unveils New Nasdaq Ticker Symbol
August 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/starling-oncology-unveils-new-nasdaq-ticker-symbol?utm_source=marketbeat.com&utm_medium=referral
The Oncology Institute Rebrands as Starling Oncology
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337442/0/en/the-oncology-institute-rebrands-as-starling-oncology.html
Oncology Institute (TOI) to Release Quarterly Earnings on Thursday
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oncology-institute-toi-to-release-quarterly-earnings-on-thursday-2026-07-30/
Jorey Chernett Acquires 18,000 Shares of Oncology Institute (NASDAQ:TOI) Stock
July 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-toi-insider-buying-and-selling-2026-07-29/
Insider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Buys 18,000 Shares
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-buying-oncology-institute-nasdaqtoi-major-shareholder-buys-18000-shares-2026-07-28/
The Oncology Institute Announces Second Quarter 2026 Financial Results Conference Call
July 27, 2026  |  quiverquant.comQ
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333583/0/en/the-oncology-institute-announces-second-quarter-2026-earnings-release-date-and-conference-call.html
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?
July 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/oncology-institute-toi-one-best-193943350.html
Oncology Institute (NASDAQ:TOI) Major Shareholder Jorey Chernett Buys 15,000 Shares
July 14, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-toi-insider-buying-and-selling-2026-07-14/
Best Cheap Stocks Under $10 to Buy Now in July
July 7, 2026  |  zacks.comhttps://www.zacks.com/commentary/2949668/best-cheap-stocks-under-10-to-buy-now-in-july?cid=cs-stocknewsapi-ft-screen_of_the_week-2949668
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and ...
July 7, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/the-oncology-institute-completes-strategic-refinancing-with-orbimed-repaying-the-outstanding-86-million-deerfield-convertible-note-strengthening-its-balance-sheet-and-improving-liquidity-1036303147
Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus
July 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/why-oncology-institute-toi-analyst-074324366.html
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323245/0/en/the-oncology-institute-completes-strategic-refinancing-with-orbimed-repaying-the-outstanding-86-million-deerfield-convertible-note-strengthening-its-balance-sheet-and-improving-liq.html
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
June 29, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2944684/the-oncology-institute-toi-soars-5-3-is-further-upside-left-in-the-stock?cid=cs-stocknewsapi-ft-tale_of_the_tape|daily_price_change_5%-2944684
Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires 18,000 Shares of Stock
June 25, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-toi-insider-buying-and-selling-2026-06-25/
Yale Podnos Sells 23,451 Shares of Oncology Institute (NASDAQ:TOI) Stock
June 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-toi-insider-buying-and-selling-2026-06-10/
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
June 9, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2934488/how-much-upside-is-left-in-the-oncology-institute-toi-wall-street-analysts-think-38-07?cid=cs-stocknewsapi-ft-tale_of_the_tape|consensus_price_target-2934488

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fulgent Genetics stock logo

Fulgent Genetics NASDAQ:FLGT

$18.56 -0.09 (-0.48%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$18.57 +0.01 (+0.05%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

GMR Solutions stock logo

GMR Solutions NYSE:GMRS

$13.37 -0.59 (-4.23%)
As of 08/14/2026 03:58 PM Eastern

GMR Solutions Inc. is a provider of emergency medical services delivering EMS and other essential out-of-hospital care in rural and urban communities. GMR Solutions Inc. is based in Lewisville, Texas.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$3.45 -0.01 (-0.29%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$3.53 +0.08 (+2.35%)
As of 08/14/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOI

$5.19 +0.06 (+1.09%)
Closing price 08/3/2026
Extended Trading
$5.19 0.00 (0.00%)
As of 08/3/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas